Article
An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
Cancer
(2012)
Disciplines
Publication Date
September 1, 2012
DOI
10.1002/cncr.26730
Citation Information
Phuong Khanh Morrow, Rashmi K. Murthy, Joe D. Ensor, Gilad S. Gordon, et al.. "An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer" Cancer Vol. 118 Iss. 17 (2012) p. 4098 - 4104 Available at: http://works.bepress.com/walter-urba/152/